Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo

Oncogene

Volumn 33, Issue 42, 2014, Pages 5047-5052

  Xu, C ^a   Lin, L ^a   Cao, G ^a   Chen, Q ^a   Shou, P ^a   Huang, Y ^a   Han, Y ^a   Wang, Y ^a   Shi, Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD8+ T cells; IFN ; immune system; mesenchymal stem cells; NK cells; tumor

Indexed keywords

ALPHA INTERFERON;

ANIMAL; APOPTOSIS; C57BL MOUSE; CANCER TRANSPLANTATION; CELL PROLIFERATION; MELANOMA, EXPERIMENTAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; INTERFERON-ALPHA; MELANOMA, EXPERIMENTAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION;

EID: 85027953716     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.458     Document Type: Article

References (29)

1. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313–319. DOI: 10.1016/j.stem.2008.03.002
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147. DOI: 10.1126/science.284.5411.143
3. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211–228. DOI: 10.1089/107632701300062859
4. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726–736. DOI: 10.1038/nri2395
5. Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha. Cell Stem Cell 2012; 11: 812–824. DOI: 10.1016/j.stem.2012.08.013
6. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393–395. DOI: 10.1080/14653240500319234
7. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007; 9: 204. DOI: 10.1186/ar2116
8. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–313. DOI: 10.1038/6529
9. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010; 20: 510–518. DOI: 10.1038/cr.2010.44
10. Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 2012; 1: 51–58. DOI: 10.5966/sctm.2011-0019
11. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012; 10: 244–258. DOI: 10.1016/j.stem.2012.02.005
12. Sensebe L, Tarte K, Galipeau J, Krampera M, Martin I, Phinney DG et al. Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell 2012; 10: 9–10, author reply 10-11. DOI: 10.1016/j.stem.2011.12.005
13. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009; 4: 206–216. DOI: 10.1016/j.stem.2009.02.001
14. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009; 27: 2614–2623. DOI: 10.1002/stem.187
15. Wang H, Cao F, De A, Cao Y, Contag C, Gambhir SS et al. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 2009; 27: 1548–1558. DOI: 10.1002/stem.81
16. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009; 69: 8862–8867. DOI: 10.1158/0008-5472.CAN-09-1912
17. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62: 3603–3608.
18. Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008; 68: 9614–9623. DOI: 10.1158/0008-5472.CAN-08-0451
19. Bracarda S, Eggermont AM, Samuelsson J. Redefining the role of interferon in the treatment of malignant diseases. Eur J Cancer 2009; 46: 284–297. DOI: 10.1016/j.ejca.2009.10.013
20. Pestka S. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 2007; 282: 20047–20051. DOI: 10.1074/jbc.R700004200
21. Pestka S. A dance between interferon-alpha/beta and p53 demonstrates collaborations in tumor suppression and antiviral activities. Cancer Cell 2003; 4: 85–87. DOI: 10.1016/S1535-6108(03)00193-4
22. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41–49. DOI: 10.1038/35095564
23. Hainaut P, Plymoth A. Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy. Curr Opin Oncol 2012; 25: 50–51. DOI: 10.1097/CCO.0b013e32835b651e
24. Wang B, Rosano JM, Cheheltani R, Achary MP, Kiani MF. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer. Expert Opin Drug Deliv 2010; 7: 1159–1173. DOI: 10.1517/17425247.2010.513968
25. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell 2012; 10: 709–716. DOI: 10.1016/j.stem.2012.05.015
26. Zou WB, Zheng HL, He TC, Chang JJ, Fu YX, Fan WM. LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response. Cancer Rese 2012; 72: 2980–2989. DOI: 10.1158/0008-5472.CAN-11-4216
27. Elzaouk L, Moelling K, Pavlovic J. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model. Exp Dermatol 2006; 15: 865–874. DOI: 10.1111/j.1600-0625.2006.00479.x
28. Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 2012; 12: 237–251. DOI: 10.1038/nrc3237
29. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012; 12: 239–252. DOI: 10.1038/nri3174